NLRP3 and gastric cancer: LncRNA ADAMTS9-AS2 served as a tumor suppressor and improved cisplatin sensitivity in gastric cancer cells through activating NLRP3-mediated pyroptotic cell death by sponging miR-223-3p (Ren et al., 2020).